Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

56.7K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.7K
Alternative RNA Splicing02:18

Alternative RNA Splicing

21.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.6K
The Nucleolus02:55

The Nucleolus

9.0K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Destabilization of Microtubules01:45

Destabilization of Microtubules

2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical demonstration of the efficacy and mechanisms of antitumor activity of dihydroartemisinin in cholangiocarcinoma xenograft: Induction of autophagy and reprogramming of metabolism.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

LncRNAs at the Crossroads of Precision Nutrition and Cancer Chemoprevention.

Cancers·2026
Same author

SARS-CoV2 and Anti-COVID-19 mRNA Vaccines: Is There a Plausible Mechanistic Link with Cancer?

Cancers·2025
Same author

The Biological Role and Clinical Significance of BECLIN-1 in Cancer.

International journal of molecular sciences·2025
Same author

Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks.

Signal transduction and targeted therapy·2025
Same author

The Anti-Inflammatory, Immunomodulatory, and Pro-Autophagy Activities of Probiotics for Colorectal Cancer Prevention and Treatment: A Narrative Review.

Biomedicines·2025

Related Experiment Video

Updated: Aug 31, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.0K

Isolation, Characterization, and Autophagy Function of BECN1-Splicing Isoforms in Cancer Cells.

Chinmay Maheshwari1, Chiara Vidoni1, Rossella Titone1

  • 1Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", 13100 Novara, Italy.

Biomolecules
|August 26, 2022
PubMed
Summary

Alternative splicing of human Beclin 1 (BECN1) generates variants that modulate autophagy and mitophagy. These BECN1 variants may be key to how cancer cells adapt to stress and influence tumor progression.

Keywords:
BH3 domain breast cancersBcl-2Beclin 1alternative splicingautophagyisoformsmitophagyovarian cancers

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.0K

Related Experiment Videos

Last Updated: Aug 31, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.0K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.0K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • Alternative splicing generates diverse protein variants from a single gene.
  • Human Beclin 1 (BECN1) is a crucial autophagy regulator and haploinsufficient tumor suppressor.
  • Reduced BECN1 expression is linked to cancer development and poor prognosis.

Purpose of the Study:

  • To isolate and characterize novel BECN1 transcript variants in human cancer cells.
  • To investigate the functional roles of these BECN1 variants in autophagy and mitophagy.
  • To explore the potential implications of BECN1 alternative splicing in cancer progression.

Main Methods:

  • Isolation and molecular characterization of BECN1 transcript variants (BECN1-α, -β, -γ).
  • Overexpression studies in human breast cancer cells (MDA-MB231).
  • Analysis of protein-protein interactions (Parkin, vacuolar protein sorting 34) and autophagy/mitophagy activity.

Main Results:

  • Three new BECN1 splicing variants (BECN1-α, -β, -γ) were identified alongside the wild-type.
  • BECN1-α stimulates autophagy and mitophagy by interacting with Parkin.
  • BECN1-β inhibits autophagy via a dominant-negative effect, while BECN1-γ shows minimal impact.

Conclusions:

  • Alternative splicing of BECN1 produces functional variants with opposing roles in autophagy.
  • BECN1 variants may allow cancer cells to fine-tune autophagy and mitophagy in response to stress.
  • Targeting BECN1 splicing could offer new therapeutic strategies for cancer treatment.